Comparing Laser Therapy and Surgery for Drug-Resistant Epilepsy
Researchers studied two surgical treatments for people with drug-resistant epilepsy: open resective surgery (ORS) and laser interstitial thermal therapy (LITT).
Plain‑language drug resistant epilepsy research: who benefits from surgery, devices, diets, and emerging treatments.
Researchers studied two surgical treatments for people with drug-resistant epilepsy: open resective surgery (ORS) and laser interstitial thermal therapy (LITT).
This study looked at how effective and safe the medication lacosamide (LCM) is for children and teenagers with drug-resistant epilepsy (DRE), which means their seizures do not respond well to standard treatments.
This study looked at the healthcare use and costs for people with drug-resistant epilepsy (DRE) who were enrolled in Medicaid and received a neurostimulator implant.
A study was conducted to evaluate the effectiveness and safety of a medication called cenobamate (CNB) in treating patients with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy that often starts in childhood.
This study looked at how children aged 8 to 17 experience long-term video-electroencephalography monitoring (LTVEM), a procedure used to diagnose epilepsy when medications don’t work.
This study looked at a specific gene called ADAM23 and its potential role in causing focal epilepsy, which is a type of seizure disorder.
Researchers studied the effects of a new treatment called repetitive transcranial magnetic stimulation (rTMS) on dogs with drug-resistant epilepsy.
Researchers conducted a systematic review to explore how advanced imaging techniques can identify neuro-inflammatory biomarkers in people with epilepsy who do not respond to medication.
Researchers studied how to create a standard way to measure recovery in adults with epilepsy who also have depression or anxiety.